CALL FOR PAPERS | Thematic Issue for Current Medicinal Chemistry


Journal: Current Medicinal Chemistry


Guest Editor(s)Alexandru Mihai GRUMEZESCU
Tentative Publication Date: June, 2019



Biomimetic scaffold which can mimic the native extracellular matrices have been developed by many research groups in order to improve the cell-scaffold interactions and to reach a new level of biocompatibility. These recent developments in the tissue construction area have lead to the idea that organ fabrication can be possible by using the available production techniques in combination with cells and growth factors to restore the function of an affected organ and even to increase the transplantation rate. Combining all those parameters together with the human body’s potential to heal in a proper environment, many products can be developed in order to diagnose and treat critical diseases from an early stage and to undertake the biggest crisis reported at the moment. The aim of this special issue is to present the latest updates in the field. For more details please visit:


Email here to submit your paper:



thematic flyer cmc

Aims & Scope – Current Pharmaceutical Biotechnology

Aims & Scope

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include:

  • DNA/protein engineering and processing
  • Synthetic biotechnology
  • Omics (genomics, proteomics, metabolomics and systems biology)
  • Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes)
  • Drug delivery and targeting
  • Nanobiotechnology
  • Molecular pharmaceutics and molecular pharmacology
  • Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes)
  • Pharmacokinetics and pharmacodynamics
  • Applied Microbiology
  • Bioinformatics (computational biopharmaceutics and modeling)
  • Environmental biotechnology
  • Regenerative medicine (stem cells, tissue engineering and biomaterials)
  • Translational immunology (cell therapies, antibody engineering, xenotransplantation)
  • Industrial bioprocesses for drug production and development
  • Biosafety
  • Biotech ethics

Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.

Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.




For more details, please visit:

EDITORS CHOICE ARTICLE – Regenerating the Womb: The Good, Bad and Ugly Potential of the Endometrial Stem Cells

Journal Name: Current Regenerative Medicine

Author(s): Flaminia Bardanzellu*, Gavino Faa, Daniela Fanni, Vassilios Fanos, Maria Antonietta Marcialis.


Graphical Abstract:


The human endometrium is a very dynamic tissue undergoing an extraordinary growth during pregnancy and, in a cyclic manner, during the reproductive life of each woman. Endometrial stem cells (ESCs), undifferentiated auto-renewable cells able to generate daughter cells showing a higher level of differentiation, play a fundamental role in endometrial regeneration and repair. Therefore, they have a great therapeutic potential in many diseases and research fields.

However, recent data suggest that an irregular function of ESCs can contribute to the pathogenesis of endometriosis and other disorders. In addition, ESCs have also been found in human leiomyomas and malignant tumours, and could be involved in their development.

In this review we analyze the enormous regenerative potential of endometrium, which is, unfortunately, not exempted from its negative effects. This coexists with the good one as two faces of the same coin and constitutes the risk behind the fundamental protective and regenerative mechanisms to defend reproduction, and therefore the miracle of life itself.



CGT-THEMATIC FLYER-Drenka Trivanovic

%d bloggers like this: